Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective.
| Autor: | Halloush, Shiraz, Alkhatib, Nimer S., Almutairi, Abdulaali R., Calamia, Mathias, Halawah, Hala, Obeng-Kusi, Mavis, Hoyle, Martin, Rashdan, Omar, Koeller, Jim, Abraham, Ivo |
|---|---|
| Zdroj: | Annals of Pharmacotherapy; Sep2023, Vol. 57 Issue 9, p1016-1024, 9p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|